One Count of Wire Fraud, Thirty Years in Prison: What a $270 Million Health Care Fraud Sentence Means for Florida Providers

A federal judge imposed a thirty year prison sentence on September 9, 2026 in a health care fraud case built on a single count of wire fraud. Not a trial conviction across a twelve count indictment. One count, entered by guilty plea five months earlier, plus $178,746,556 in restitution. If you run a pharmacy, a clinic, or a billing operation in Florida and you have been telling yourself that pleading to one count caps your exposure, that assumption deserves a harder look.

A single count of conviction sets the statutory ceiling. Loss, kickbacks, role, and conduct on pretrial release decide where inside that ceiling a court lands.

Key Takeaways

• A guilty plea to one count of wire fraud under 18 U.S.C. § 1343 produced a thirty year sentence and $178.7 million in restitution.
• Section 1343 carries a twenty year maximum in the ordinary case and a thirty year maximum where the offense affects a financial institution.
• Kickbacks charged under 42 U.S.C. § 1320a-7b drive guideline enhancements even when the single count of conviction is wire fraud.
• Committing a federal offense while on pretrial release triggers a consecutive term under 18 U.S.C. § 3147 and a guideline enhancement.
• The Southern District of Florida hosts one of nine federal health care fraud strike forces, and the same sentencing math applies here.

What Actually Happened

The case came out of the Central District of California and targeted Medi-Cal, California's Medicaid program. According to the Justice Department, a pharmacy operator worked with a pharmacist who owned the pharmacy and a nurse practitioner who signed the prescriptions. Medi-Cal had temporarily suspended its prior authorization requirement while transitioning to a new prescription drug payment system. That suspension was the opening.

With prior authorization gone, the pharmacy billed for high reimbursing, non contracted generic drugs that would otherwise have needed approval first. Pain creams. A folate tablet sold over the counter. One prescription for meloxicam 5 mg, a generic that typically costs between $5 and $25 for a thirty day supply, was billed at roughly $13,424.

The government did not need a novel theory here. It needed the claims data. A generic that retails for $5 to $25 billed at roughly $13,424 is the kind of line item that surfaces the moment anyone runs the numbers.

Over eleven months the operation generated at least $269,120,829 in claims and Medi-Cal paid approximately $178,746,556. The government alleges the medications were medically unnecessary, frequently never dispensed at all, and obtained through kickbacks paid to patient marketers and to the nurse practitioner for signing pre filled prescriptions she never reviewed.

Two facts from the press release matter more than the headline number. The defendant pleaded guilty in April 2026 to a single count of wire fraud. And he committed the offense while on pretrial release in a separate federal case in the same district.

What the Government Is Actually Building

This was a Fraud Division case, prosecuted by the Health Care Fraud Section alongside the local United States Attorney's Office, with the FBI, HHS-OIG, and a state attorney general's office investigating together. The Health Care Fraud Strike Force Program now runs nine strike forces and has charged more than 6,200 defendants who billed federal programs and private insurers over $45 billion since 2007. South Florida is one of those nine and among the most active. Any South Florida federal criminal defense practice sees the same sequence: an HHS-OIG subpoena, then claims data analysis, then a target letter.

By the time agents are in the lobby, the claims analysis is finished. The visit is not the start of the investigation. It is the point where the government starts collecting statements to go with the data it already has.

Notice what the government targeted. This was not a physician making close calls on medical necessity. It was a payment system with a temporary gap and operators who found the gap and billed into it at volume. Prior authorization suspensions. Telehealth flexibilities. Emergency waivers. Revalidation backlogs. Each one opens a window, and the government has the claims data to identify who ran through it and how fast. Florida providers whose billing curve bent sharply upward during a waiver period should assume the analytics already flagged them.

Florida is not a bystander. On September 4, 2026 the Department announced prison sentences for two Florida men in a $34.8 million orthotic brace scheme. The state also prosecutes under Fla. Stat. § 409.920, so one set of facts can produce both a federal indictment and a state Florida Medicaid fraud charge.

Exposure, Statutes, and How Thirty Years Happens

Wire fraud under 18 U.S.C. § 1343 carries a twenty year statutory maximum in the ordinary case. The maximum rises to thirty years where the violation affects a financial institution or relates to a presidentially declared major disaster or emergency. That distinction is a ten year swing that turns on how the count is charged and what the plea agreement recites. Anyone negotiating a fraud plea should know which version of § 1343 is on the table before signing.

For comparison, health care fraud under 18 U.S.C. § 1347 carries ten years per count. Paying or receiving remuneration for referrals reimbursed by a federal health care program violates the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b, another ten years per count. Moving the proceeds afterward adds 18 U.S.C. § 1956, twenty years per count.

The count of conviction sets the ceiling. Everything else decides where inside that ceiling the court lands. Under U.S.S.G. § 2B1.1, loss drives the offense level, and here the intended loss ran near $270 million. Kickbacks, sophisticated means, victim count, abuse of trust, and a leadership role each stack on top, and conduct never charged can still count as relevant conduct. Committing the offense while on release in another federal case triggers 18 U.S.C. § 3147, which adds a consecutive term and a guideline enhancement, and it strips out most of the mitigation an 18 U.S.C. § 3553(a) argument would otherwise rest on.

Forfeiture runs on its own track under 18 U.S.C. § 982 and reaches property traceable to the offense. Restitution is not capped by what a defendant still has. And the 2026 guideline amendments take effect November 1, 2026, changing the economic crime calculations. Whether a client is sentenced before or after that date can matter.

The Mistakes That Cost People the Most, and They Happen Early

Talking to agents without counsel. HHS-OIG and FBI agents who appear at a clinic already have the claims data. They are there to lock in statements, and a false or incomplete answer becomes its own federal charge.

Producing records without a strategy. A grand jury subpoena or an HHS-OIG subpoena is not a document request for an office manager to handle. Federal grand jury subpoena defense starts with scope, privilege, and preservation, before anything leaves the building.

Assuming an audit is only an audit. A ZPIC, UPIC, or TPE audit can convert into a criminal referral quietly. Prepayment review, a payment suspension, or a sudden revalidation demand is often the first visible sign that a criminal investigation is already open.

Treating a company problem as one person's problem. In pharmacy and clinic cases the government charges owners, prescribers, marketers, and billers. A pharmacist DEA defense attorney and a nurse practitioner fraud defense lawyer may be looking at the same facts from opposite sides of a conflict.

What a Real Defense Looks Like at This Stage

Pre-indictment work is where health care fraud cases are actually decided. A pre-indictment defense lawyer who gets in before the charging decision can correct the government's loss model, separate a client from conduct that belongs to someone else, present medical necessity documentation the agents never collected, and argue that the client is a witness or a subject rather than a target.

"Billed is not paid. Paid is not loss. Intended loss requires proof of intent, not arithmetic. Every dollar removed from the loss figure before charging is worth more than any argument made after conviction."— Aaron M. Cohen, AMC Defense Law

Loss is the largest lever in a fraud case. Billed is not paid. Paid is not loss. Intended loss requires proof of intent, not arithmetic. Every dollar removed from the loss figure before charging is worth more than any argument made after conviction.

Kickback allegations deserve early attention. Marketing arrangements, medical director agreements, and per patient compensation structures often have a defensible commercial explanation and sometimes fall inside a safe harbor. That analysis lands harder with a prosecutor deciding whether to charge than with a jury deciding whether to convict.

The cooperation decision has to be made with clear eyes. A proffer agreement protects less than clients expect, and a proffer given before counsel understands the government's theory can hand the prosecution the intent evidence it was missing. And if charges are coming anyway, PSR objections and guideline objections get drafted from records gathered during the investigation, not three weeks before a hearing.

Why the Timing Is Not Flexible

Charging decisions stay fluid for a long time and then stop. Prosecutors decide which counts to bring, whether to charge a financial institution theory, whether to add money laundering, and which loss figure to allege. Those choices set the ceiling and the floor before a defense lawyer files anything in court.

The thirty year sentence out of California shows the far end of that process. Everything that produced it, the loss figure, the kickback allegations, the single count carrying the higher maximum, was locked in long before the sentencing hearing. Whether the first sign is a federal target letter, a grand jury subpoena, or agents in the lobby, the window to shape the outcome is open now and it closes quietly.

Common Questions

Under Federal Health Care Fraud Investigation in Florida?

AMC Defense Law represents pharmacies, clinics, prescribers, billing companies, and executives in federal health care fraud investigations and prosecutions in Florida and nationwide. If you have received a federal target letter, a grand jury subpoena, an HHS-OIG subpoena, or a visit from federal agents, the conversation should happen before you respond. Consultations are confidential. Call 561.542.5494.

Pre-indictment is where the loss figure, the kickback allegations, and the count of conviction are still open questions. That is the window worth using.

If you or your loved ones have been arrested or are under federal investigation involving health care fraud in Florida, call Aaron M. Cohen for a confidential consultation, 24 hours a day, to get help.

This article is provided for general informational purposes only and does not constitute legal advice. Reading it does not create an attorney client relationship with AMC Defense Law or any of its attorneys. Every case turns on its own facts and applicable law, and outcomes described here do not predict results in any other matter. If you are the subject of a federal investigation or have been charged with a crime, consult a qualified attorney about your specific situation.

About the author: Aaron M. Cohen, Esq. is the founding attorney of AMC Defense Law (The Law Offices of Aaron M. Cohen, P.A.), a criminal defense firm based in Boca Raton, Florida. With more than 30 years of experience, Mr. Cohen represents individuals and entities in complex federal and state criminal investigations and prosecutions nationwide.